These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 2190023
21. [Clinical evaluation of serum S100ao protein in patients with urogenital diseases and healthy volunteers]. Kikuchi T, Morita T, Hashimoto S, Hara Y, Moriguchi H, Ishikawa S, Kobayashi Y, Ishiyama S, Goto K, Tozuka K. Hinyokika Kiyo; 1990 Oct; 36(10):1117-23. PubMed ID: 2264539 [Abstract] [Full Text] [Related]
24. [Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma]. Ikeda K, Terashima M, Ishida K, Okamoto K, Suzuki S, Murakami K, Ohtsu T, Suzuki K, Niitsu Y, Obonai H. Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):677-82. PubMed ID: 3355186 [Abstract] [Full Text] [Related]
25. [Immunosuppressive acidic protein (IAP) in gynecologic malignant tumors and its relationship with other immunosuppressive substances and cell-mediated immunity]. Takada M. Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):237-44. PubMed ID: 6881975 [Abstract] [Full Text] [Related]
26. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery]. Tsukamoto S, Ishikawa S, Yamauchi A, Saitou S. Hinyokika Kiyo; 2000 Oct; 46(10):695-9. PubMed ID: 11215193 [Abstract] [Full Text] [Related]
27. How do symptoms have an impact on the prognosis of renal cell carcinoma? Kawata N, Nagane Y, Yamaguchi K, Ichinose T, Hirakata H, Takahashi S. Int J Urol; 2008 Apr; 15(4):299-303. PubMed ID: 18380815 [Abstract] [Full Text] [Related]
28. [Clinical investigation of serum immunosuppressive acidic protein (IAP) in patients with gastric cancer]. Kageyama T, Oyabu H, Ohshiba S. Gan No Rinsho; 1986 Sep; 32(11):1416-20. PubMed ID: 3773269 [Abstract] [Full Text] [Related]
29. [Clinical evaluation of serum immunosuppressive acidic protein (IAP) and acid soluble glycoproteins (ASP) in patients with malignant tumors]. Shibasaki K, Soga K, Toshima M, Aikawa K, Tsuruya T, Itoh T, Takahashi Y, Tsuchimochi M, Mataga I, Tsuchikawa K. Shigaku; 1989 Aug; 77(2):701-11. PubMed ID: 2489324 [Abstract] [Full Text] [Related]
30. Long-term outcome of postoperative interferon-alpha adjuvant therapy for non-metastatic renal cell carcinoma. Gotoh A, Shirakawa T, Hinata N, Wada Y, Hara I, Fujisawa M, Kawabata G, Okada H, Arakawa S, Kamidono S. Int J Urol; 2004 May; 11(5):257-63. PubMed ID: 15147539 [Abstract] [Full Text] [Related]
31. [Immunosuppressive acidic glycoprotein (IAP) and immunosuppressive substance]. Ogoshi K, Kondoh Y, Nakasaki H, Tajima T, Mitomi T. Gan No Rinsho; 1983 Aug; 29(9):987-90. PubMed ID: 6688640 [Abstract] [Full Text] [Related]
34. [Studies of the cellular immune response in patients with urinary bladder carcinoma. X. Evaluation of serum IAP and ASP levels]. Nishio S, Ozaki Y, Wada S, Kawakita J, Maekawa M. Hinyokika Kiyo; 1984 Apr; 30(4):449-57. PubMed ID: 6485956 [Abstract] [Full Text] [Related]
35. [Clinical significance of serum acid soluble glycoproteins (ASP) and immunosuppressive acidic protein (IAP) in inflammatory diseases and liver diseases]. Shibasaki K, Soga K, Toshima M, Aikawa K, Itoh T, Takahashi Y, Tsuchimochi M, Mataga I, Tsuchikawa K, Kato J. Shigaku; 1989 Oct; 77(3):1031-41. PubMed ID: 2489330 [Abstract] [Full Text] [Related]
36. [Significance of immunosuppressive acidic protein in the diagnosis and follow-up of patients with ovarian cancer, in particular as a marker for chemotherapeutic effects]. Shimizu Y, Akagaki E, Hirota K, Kono M, Miura S, Okudaira Y, Kurachi K. Nihon Sanka Fujinka Gakkai Zasshi; 1986 Apr; 38(4):554-60. PubMed ID: 3701144 [Abstract] [Full Text] [Related]
37. [A case of renal cell carcinoma with an extremely high serum carcinoembryonic antigen level]. Tanaka K, Chokyu H, Sugita Y, Yoshimura K, Umezu K. Hinyokika Kiyo; 1996 May; 42(5):365-7. PubMed ID: 8752540 [Abstract] [Full Text] [Related]
38. [Investigation of serum immunosuppresive acidic protein levels in gynecological tumor]. Zhang W, Wang P, Zhao Y. Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):194-6. PubMed ID: 11601039 [Abstract] [Full Text] [Related]
39. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N. Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117 [Abstract] [Full Text] [Related]